!!Projects per year
Samenvatting
Background: Genetics play an important role in the development of metabolic dysfunction-associated steatohepatitis (MASH). Specifically, a combination of single nucleotide polymorphisms in known MASH-modifying genes - PNPLA3 (rs738409 C>G), TM6SF2 (rs58542926 C>T), GCKR (rs1260326 C>T), and MBOAT7 (rs641738 C>T) - has been integrated into a polygenic risk score for hepatic fat content (PRS-HFC). However, the impact of this polygenic risk on the hepatocyte-specific inflammatory secretome is unclear. Here, we aimed to identify inflammatory proteins related to an increased polygenic risk for MASH using a human stem cell-based in vitro model representing genetic variability in the MASH population.
Methods: 90 human skin-derived precursor (hSKP) cell lines were genotyped and classified according to their PRS-HFC. Five cell lines were selected from the low (RClow) and high (RChigh) risk categories and differentiated to hepatic cells (hSKP-HPCs) over 24 days. These cultures were then exposed for 24 hours to a mix consisting of fatty acids, fructose, lipopolysaccharide and TNF-alpha, mimicking a ‘MASH’ phenotype, or vehicle-matched control medium. Intracellular lipids were quantified using flow cytometry following BODIPY™ 493/503 staining for neutral lipids to validate the PRS-HFC in this in vitro system. Protein biomarkers were determined in the cell culture supernatant using the Olink® multiplex analysis platform.
Results: MASH-induced hSKP-HPC RChigh cultures exhibited a 3.5-fold increase in lipid load compared to RClow cultures (p = 0,0004). RChigh cultures secreted remarkably more interleukin 6 (IL6) than RClow cultures (5.2-fold, p < 0.0001) in response to the ‘MASH’ mix. While RClow and RChigh cultures secreted similar amounts of CC motif chemokine ligand (CCL) 2 (p = 0.053) and CXC motif chemokine ligand (CXCL) 10 (p = 0.56), an increased secretion in RChigh was also found for CCL7 (1.5-fold, p = 0.0058), CCL8 (7.1-fold, p < 0.0001), CCL19 (3.8-fold, p < 0.0001), CXCL8 (1.8-fold, p = 0.0007), and colony stimulating factor 3 (CSF3) (2.4-fold, p < 0.0001).
Conclusion: This in vitro study suggests that carriage of multiple genetic risk factors for MASH stimulates an altered inflammatory secretome involving at least IL6, CCL7, CCL8, CCL19, CXCL8, and CSF3. Employing pathway analysis and sequencing techniques will further uncover the underlying mechanisms responsible for the altered secretion of inflammatory proteins.
Methods: 90 human skin-derived precursor (hSKP) cell lines were genotyped and classified according to their PRS-HFC. Five cell lines were selected from the low (RClow) and high (RChigh) risk categories and differentiated to hepatic cells (hSKP-HPCs) over 24 days. These cultures were then exposed for 24 hours to a mix consisting of fatty acids, fructose, lipopolysaccharide and TNF-alpha, mimicking a ‘MASH’ phenotype, or vehicle-matched control medium. Intracellular lipids were quantified using flow cytometry following BODIPY™ 493/503 staining for neutral lipids to validate the PRS-HFC in this in vitro system. Protein biomarkers were determined in the cell culture supernatant using the Olink® multiplex analysis platform.
Results: MASH-induced hSKP-HPC RChigh cultures exhibited a 3.5-fold increase in lipid load compared to RClow cultures (p = 0,0004). RChigh cultures secreted remarkably more interleukin 6 (IL6) than RClow cultures (5.2-fold, p < 0.0001) in response to the ‘MASH’ mix. While RClow and RChigh cultures secreted similar amounts of CC motif chemokine ligand (CCL) 2 (p = 0.053) and CXC motif chemokine ligand (CXCL) 10 (p = 0.56), an increased secretion in RChigh was also found for CCL7 (1.5-fold, p = 0.0058), CCL8 (7.1-fold, p < 0.0001), CCL19 (3.8-fold, p < 0.0001), CXCL8 (1.8-fold, p = 0.0007), and colony stimulating factor 3 (CSF3) (2.4-fold, p < 0.0001).
Conclusion: This in vitro study suggests that carriage of multiple genetic risk factors for MASH stimulates an altered inflammatory secretome involving at least IL6, CCL7, CCL8, CCL19, CXCL8, and CSF3. Employing pathway analysis and sequencing techniques will further uncover the underlying mechanisms responsible for the altered secretion of inflammatory proteins.
| Originele taal-2 | English |
|---|---|
| Titel | The Liver Meeting: 2024 Abstracts |
| Uitgeverij | Wolters Kluwer Health |
| Pagina's | S35-S35 |
| Aantal pagina's | 1 |
| Volume | 80 |
| Uitgave | S1 |
| DOI's | |
| Status | Published - 1 okt. 2024 |
| Evenement | AASLD - The 75th Liver Meeting - San Diego Convention Center, San Diego, United States Duur: 15 nov. 2024 → 19 nov. 2024 https://www.aasld.org/the-liver-meeting |
Publicatie series
| Naam | Hepatology |
|---|---|
| Uitgeverij | John Wiley and Sons Ltd |
| ISSN van geprinte versie | 0270-9139 |
Conference
| Conference | AASLD - The 75th Liver Meeting |
|---|---|
| Land/Regio | United States |
| Stad | San Diego |
| Periode | 15/11/24 → 19/11/24 |
| Internet adres |
Vingerafdruk
Duik in de onderzoeksthema's van 'Carriage of multiple genetic risk factors for MASH stimulates an altered inflammatory secretome in a human stem cell-based in vitro model: San Diego, California, Nov 15-19, 2024'. Samen vormen ze een unieke vingerafdruk.Projecten
- 1 Afgelopen
-
FWOSB134: Ontwikkeling en toepassing van een etiologisch anti-MAFLD geneesmiddelenontwikkelingsplatform, gebaseerd op humane stamcellen en gericht op schildklierhormoon signalering
Vanhaecke, T. (Administrative Promotor), Boeckmans, J. (Co-Promoter), Marcelino Rodrigues, R. (Co-Promoter) & Gatzios, A. (Mandataris)
1/11/22 → 31/10/26
Project: Fundamenteel
Onderzoekersoutput
- 7 Citaties
- 1 Poster
-
Carriage of multiple genetic risk factors for MASH stimulates an altered inflammatory secretome in a human stem cell-based in vitro model
Gatzios, A., Rombaut, M., De Kock, J., De Win, D., Heymans, A., Rogiers, V., Rodrigues, R., Boeckmans, J. & Vanhaecke, T., 15 nov. 2024.Onderzoeksoutput: Poster
Prijzen
-
Belgian Society of Pharmaceutical Sciences Congress Grant
Gatzios, A. (Recipient), 24 dec. 2024
Prijs: Prize (including medals and awards)
-
FWO Grant for participation in a conference abroad
Gatzios, A. (Recipient), 11 sep. 2024
Prijs: Prize (including medals and awards)
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver